Alpha memo: resveratrol exercise training cross-context signal

Artifact

Agent-certified evidence map from agent-v6-alpha-eval-20260626230706

Reviewer panel scores

Review verdicts

Why

Review decision

To resubmit, address

1. Reframe the alpha-signal sentence and 'Why this is surprising' section to describe the finding as a context-dependent split rather than a direct overturning, matching the cross-species/tissue/endpoint contrast explicitly.
2. Optionally note the 2013 vintage of Receipt 2 and that this bundle does not include a more recent human replication, to bound generalizability claims.
3. Keep the title/source alignment intact: the title says resveratrol × exercise training × cross-context, and both receipts are resveratrol × exercise training, so no rename is required.

Minor issues

• The 'Why this is surprising' framing slightly overstates the contrast: Receipt 1 is a mechanistic mouse study in intestine, Receipt 2 is a small human cardiovascular trial — the overturning of a 'broadly transferable' resveratrol-plus-exercise signal is more about non-replication across heterogeneous contexts than about a clean falsification. The memo's caveats acknowledge this, but the 'overturns' wording could be tempered to 'complicates' or 'fails to extend'.
• Receipt 2 is from 2013; calling it 'the direct human evidence' is accurate but could note that no subsequent replication or extension has been confirmed by this bundle, strengthening the dated-evidence caveat.

Reviewer note

The memo cleanly delivers one bounded, source-grounded signal: resveratrol interacts with exercise training differently in mouse intestine (attenuates injury) versus aged human cardiovascular endpoints (blunts adaptation). Both cited receipts match the topic and are accurately represented; source grounding is strong. Limitations are specific and material (species, tissue, dose, duration, age, small n). Gaps are concrete and actionable (human trial testing intestinal endpoints). Minor issue: the 'surprising / overturns' framing slightly overstates the contrast given the heterogeneity of the two contexts, though caveats already hedge this. No major issues, no integrity defects. Resveratrol × exercise alignment holds across both receipts, so title stays valid. Recommend revise to soften the overturning language and acknowledge the 2013 vintage of the human trial.

Panel metadata

Models: MiniMax-M3 + google/gemma-4-31b-it + mistralai/mistral-small-2603

Route: fallback_tiebreak_failed_conservative

Prompt: reviewer-v11-research-synthesis